Quantitative analysis of iron concentration and expression of ferroportin 1 in the cortex and hippocampus of rats induced by cerebral ischemia

Journal of Clinical Neuroscience

Volumn 16, Issue 11, 2009, Pages 1466-1472

  Li, Lin ^a   Li, Yan wei ^a,b   Zhao, Jin ying ^b   Liu, Yue Ze ^a   Holscher, Christian ^c  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b Shaoyang Medical College   (China)

^c UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Brain; Ferroportin; Iron; Ischemia

Indexed keywords

FERROPORTIN 1; IRON; MESSENGER RNA;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BRAIN CORTEX; BRAIN ISCHEMIA; COMMON CAROTID ARTERY; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IRON OVERLOAD; LIGATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3,3'-DIAMINOBENZIDINE; ANALYSIS OF VARIANCE; ANIMALS; BRAIN ISCHEMIA; CATION TRANSPORT PROTEINS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON; MAGNETIC RESONANCE IMAGING; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; STATISTICS AS TOPIC; TIME FACTORS;

EID: 70449525134     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2009.01.020     Document Type: Article

References (40)

1. Zhou B., Westaway S.K., Levinson B., et al. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 28 (2001) 345-349
2. Ke Y., and Qian Z.M. Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol 2 (2003) 246-253
3. Qian Z.M., and Shen X. Brain iron transport and neurodegeneration. Trends Mol Med 7 (2001) 103-108
4. Fleming M.D. The regulation of hepcidin and its effects on systemic and cellular iron metabolism. Hematology Am Soc Hematol Educ Program (2008) 151-158
5. Ganz T. Cellular iron: ferroportin is the only way out. Cell Metab 1 (2005) 155-157
6. Donovan A., Brownlie A., Zhou Y., et al. Positional cloning of zebrafish ferroportin 1 identifies a conserved vertebrate iron exporter. Nature 403 (2000) 776-781
7. Jeong S.Y., and David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem 278 (2003) 27144-27148
8. Wu L.J., Leenders A.G., Cooperman S., et al. Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier. Brain Res 1001 (2004) 108-117
9. Qian Z.M., and Ke Y. Rethinking the role of ceruloplasmin in brain iron metabolism. Brain Res Rev 35 (2001) 287-294
10. De Domenico I., Ward D.M.V., Musci G., et al. Iron overload due to mutations in ferroportin. Haematologica 91 (2006) 92-95
11. Hallgren R., Terent A., Wide L., et al. Cerebrospinal fluid ferritin in patients with cerebral infarction or bleeding. Acta Neurol Scand 61 (1980) 384-392
12. Davalos A., Fernandez-Real J.M., Ricart W., et al. Iron-related damage in acute ischemic stroke. Stroke 25 (1994) 1543-2546
13. Lipscomb DL, Hurn PD, Gorman LK, et al. Changes in low molecular weight iron during hyperglycemic incomplete global ischemia. FASEB J 1996;10:A28.
14. 2. J Cereb Blood Flow Metab 9 (1989) 65-70
15. Wakita H., Tomimoto H., Akiguchi I., et al. Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: an immunohistochemical study. Acta Neuropathol (Berl) 87 (1994) 484-492
16. Danielisova V., Gottlieb M., and Burda J. Iron deposition after transient forebrain ischemia in rat brain. Neurochem Res 27 (2002) 237-242
17. Wakita H., Tomimoto H., Akiguchi I., et al. Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res 924 (2002) 63-70
18. Umemura S., Yoshida T., Iwayama K., et al. Experimental study of ischemic rat brain: correlation of pathological findings with rCBF. Brain Nerve 34 (1982) 179-185
19. Tsuchiya M., Sako K., Yura S., et al. Cerebral blood flow and histopathological changes following permanent bilateral carotid artery ligation in Wistar rats. Exp Brain Res 89 (1992) 87-92
20. Hattori H., Takeda M., Kudo T., et al. Cumulative white matter changes in the gerbil brain under chronic cerebral hypoperfusion. Acta Neuropathol (Berl) 84 (1992) 437-442
21. Millan M., Sobrino T., Castellanos M., et al. Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke. Stroke 38 (2007) 90-95
22. Ferro JM, Davalos A. Other neuroprotective therapies on trial in acute stroke. Cerebrovasc Dis 2006;21(Suppl.):127-130.
23. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 350 (2004) 2383-2397
24. Bishop G., and Robinson S. Quantitative analysis of cell death and ferritin expression in response to cortical iron, implications for hypoxia-ischemia and stroke. Brain Res 907 (2001) 175-187
25. Ishimaru H., Ishikawa K., Ohe Y., et al. Activation of iron handling system within the gerbil hippocampus after cerebral ischemia. Brain Res 726 (1996) 23-30
26. Shohami E., Beit-Yannai E., Horowitz M., et al. Oxidative stress in closed-head injury: brain antioxidant capacity as an indicator of functional outcome. J Cereb Blood Flow Metab 17 (1997) 1007-1019
27. Kondo Y., Ogawa N., Asanuma M., et al. Regional differences in late-onset iron deposition, ferritin, transferrin, astrocyte proliferation and microglial activation after transient forebrain ischemia in rat brain. J Cereb Blood Flow Metab 15 (1995) 216-226
28. Kidwell C.S., Saver J.L., Starkman S., et al. Late secondary ischemic injury in patients receiving intra arterial thrombolysis. Ann Neurol 52 (2002) 698-703
29. Davalos A., Castillo J., Marrugat J., et al. Body iron stores and early neurologic deterioration in acute cerebral infarction. Neurology 54 (2000) 1568-1574
30. Fraenkel P.G., Traver D., Donovan A., et al. Ferroportin 1 is required for normal iron cycling in zebrafish. J Clin Invest 115 (2005) 1532-1541
31. Canonne-Hergaux F., Donovan A., Delaby C., et al. Comparative studies of duodenal and macrophage ferroportin proteins. Am J Physiol Gastrointest Liver Physiol 290 (2006) G156-G163
32. Abboud S., and Haile D.J. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275 (2000) 19906-19912
33. Jiang D.H., Ke Y., Cheng Y.Z., et al. Distribution of ferroportin1 protein in different regions of developing rat brain. Dev Neurosci 24 (2002) 94-98
34. Yang F., Wang X., Haile D.J., et al. Iron increases expression of iron-export protein MTP1 in lung cells. Am J Physiol Lung Cell Mol Physiol 283 (2002) L932-L939
35. Knutson M.D., Vafa M.R., Haile D.J., et al. Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood 102 (2003) 4191-4197
36. Donovan A., Lima C.A., Pinkus J.L., et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 1 (2005) 191-200
37. Nemeth E., Tuttle M.S., Powelson J., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004) 2090-2093
38. Beutler E. "Pumping" iron: the proteins. Science 306 (2004) 2051-2053
39. Ganz T. Hepcidin and its role in regulating systemic iron metabolism. Hematol Am Soc Hematol Educ Program 2 (2006) 29-35
40. Laftah A.H., Raja K.B., Latunde-Dada G.O., et al. Effect of altered iron metabolism on markers of haem biosynthesis and intestinal iron absorption in mice. Ann Hematol 84 (2005) 177-182